NSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.
Dr. Lal Pathlabs Ltd: key numbers
- Share price
- ₹1,907.20
- Market cap
- ₹32,012 Cr
- Revenue (annual)
- ₹2,763 Cr
- Net profit (annual)
- ₹504.8 Cr
- P/E (TTM)
- 59.1×Sector 52.3×
- Promoter holding
- 52.93%-0.26% QoQ
- FII holding
- 18.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Lal Pathlabs Ltd
All →Dr. Lal Pathlabs Board Meeting Date
Dr. Lal PathLabs updated its 4 November 2026 board meeting notice to add a possible second interim dividend. The meeting will also approve unaudited quarterly results.
Dr. Lal Pathlabs Acquisition Worth ₹30.3 Cr
Dr. Lal PathLabs subscribed to WOS PUPL equity to fund PUPL's buyout of remaining 30% in CentraPath Labs for ₹30.3 Crore. CentraPath becomes a wholly owned subsidiary.
- Value
- ₹30.30 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, received from its RTA.
Dr. Lal Pathlabs Legal & Regulatory
Dr. Lal PathLabs disclosed an ITAT tax appeal against a favorable order for Rs.32.66 Crore ESOP expense relief (AY 2022-23). The company expects no material financial impact.
- Value
- ₹32.66 Cr
Dr. Lal Pathlabs Other Announcement
Dr. Lal PathLabs reported PIT disclosures for trades by designated persons and its Employee Welfare Trust, totaling approximately ₹0.83 Crore. These involved ESOP allotments and market sales.
- Value
- ₹0.09 Cr
Dr. Lal Pathlabs Acquisition Worth ₹38 Cr
Dr. Lal Path Labs' subsidiary completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana, for Rs.38.00 Crore. The target is now a subsidiary.
- Value
- ₹38.00 Cr
Other business update announcements
All →Timken India Business Update
Timken India received two BIS licences for roller bearings at its Bharuch plants. The licences enable certified supply to regulated sectors, with no financial value disclosed.
63 Moons Technologies Business Update
63 moons' material subsidiary 63SATS entered an advertisement agreement with Bennett Coleman. No value is disclosed; the deal supports brand marketing and working capital.
Shri Hare-Krishna Sponge Iron Business Update
Shri Hare-Krishna Sponge Iron postponed commercial production of its 2 MW biomass captive power plant. Production is now expected in November 2026.
- biomass captive power capacity
- 2.0 MW
Western Overseas Study Abroad Business Update
Western Overseas Study Abroad attended the Russia–India Business Forum in Kazan in October 2026. The visit only explored possible collaborations, with no agreement signed.
Atlantaa Business Update
Atlantaa Ltd informed exchanges that MSRDC has reinvited bids for the Bhandara-Gadchiroli Expressway BG-03 package. Bid documents open November 6, 2026, with bids due December 23, 2026.
Racl Geartech Business Update
RACL Geartech will host a shareholder plant visit at its Gajraula facility on 30 November 2026. Registration closes 15 November 2026, with limited seats.